Liver transplantation (LT) is the standard treatment for hepatocellular carcinoma (HCC) and end-stage liver disease, with excellent long-term outcomes despite the increasing use of extended criteria donors due to organ shortage. As traditional evaluation criteria have become insufficient, new indicators such as Arterial and Biliary Complication-Free Survival (ABCFS) have been developed to better assess post-transplant outcomes. Primary objective: To assess, in a large-scale study, whether the procurement technique influences liver transplantation outcomes in terms of arterial and biliary complication-free survival.
Study Type
OBSERVATIONAL
Enrollment
1,810
Arterial and Biliary Complication-Free Survival (ABCFS) at 3 years
Time frame: at 3 years post-transplantation
Postoperative complications at 90 days
Time frame: at 90 days post-transplantation
Type of Biliary complications
Time frame: Up to 3 years post-transplantation
Type of Arterial complications
Time frame: Up to 3 years post-transplantation
Occurrence of vascular injuries observed following organ procurement
Time frame: Peri-procedural period (during procurement and immediately post-procurement)
Rehospitalization Rate Post-LT
Number of rehospitalizations per patient occurring after the initial transplantation hospitalization.
Time frame: Up to 3 years post-transplantation
Duration of Rehospitalizations Post-LT
Length of stay for each rehospitalization occurring after the initial transplantation hospitalization.
Time frame: Up to 3 years post-transplantation
Reasons for Rehospitalizations Post-LT
Reason for each rehospitalization occurring after the initial transplantation hospitalization, categorized by diagnosis.
Time frame: Up to 3 years post-transplantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.